JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gelkop, S.
Right arrow Articles by Isakov, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gelkop, S.
Right arrow Articles by Isakov, N.

J Biol Chem, Vol. 274, Issue 31, 21519-21527, July 30, 1999


T Cell Activation Stimulates the Association of Enzymatically Active Tyrosine-phosphorylated ZAP-70 with the Crk Adapter Proteins*

Sigal Gelkop and Noah IsakovDagger

From the Department of Microbiology and Immunology, Faculty of Health Sciences, and the Cancer Research Center, Ben Gurion University of the Negev, Beer Sheva 84105, Israel

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Engagement of the T cell antigen receptor initiates signal transduction involving tyrosine phosphorylation of multiple effector molecules and the formation of multimolecular complexes at the receptor site. Adapter proteins that possess SH2 and SH3 protein-protein interaction domains are implicated in the assembly of cell activation-induced signaling complexes. We found that Crk adapter proteins undergo activation-induced interaction with the zeta -chain associated protein (ZAP-70) tyrosine kinase in the human T cell line, Jurkat. Incubation of various glutathione S-transferase fusion proteins with a lysate of activated Jurkat cells resulted in selective association of ZAP-70 with Crk, but not Grb2 or Nck, adapter proteins. In addition, tyrosine-phosphorylated ZAP-70 co-immunoprecipitated with Crk from a lysate of activated Jurkat cells, and ZAP-70 association with GST-Crk was observed in a lysate of activated human peripheral blood T cells. Association between the two molecules was mediated by direct physical interaction and involved the Crk-SH2 domain and phosphotyrosyl-containing sequences on ZAP-70. The association required intact Lck, considered to be an upstream regulator of ZAP-70, because it could not take place in activated JCaM1 cells, which express normal levels of ZAP-70 but are devoid of Lck. Finally, glutathione S-transferase-Crk fusion proteins were found to interact predominantly with membrane-residing tyrosine-phosphorylated ZAP-70 that exhibited autophosphorylation activity as well as phosphorylation of an exogenous substrate, CFB3. These findings suggest that Crk adapter proteins play a role in the early activation events of T lymphocytes, apparently, by direct interaction with, and regulation of, the membrane-residing ZAP-70 protein tyrosine kinase.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Engagement of the T cell antigen receptor (TCR)1 triggers signal transduction pathways that directly regulate T cell activation and differentiation (1, 2). Although many of the individual components of the TCR-linked signaling pathway are physically separated in resting cells, upon engagement of the receptor, they reassemble into functional complexes at the site of contact with major histocompatibility complex-presenting peptide antigen on the surface of the antigen-presenting cells (3). The reassembly process directs enzymes, their corresponding substrates, and additional effector molecules to the receptor site, in a temporally and spatially regulated manner, which ensures an efficient signaling leading to cell activation. The same mechanism ensures that the level of signaling in unstimulated cells remains below the critical threshold required for cell activation.

The earliest detectable biochemical event in activated T cells is the phosphorylation of multiple protein substrates on tyrosine residues. Therefore, protein tyrosine kinases (PTKs) that mediate this activity play a critical role in the early phases of the activation response by up-regulating critical enzymes and promoting the assembly of the multimolecular complexes. Non-receptor PTKs that mediate these functions in T cells include the Src family members, Lck and Fyn, and the Syk family members, ZAP-70 and Syk (1, 2). A fraction of Fyn and Lck, which are constitutively associated with the TCR and CD4/CD8 cytoplasmic tails, respectively, appears to phosphorylate critical tyrosine residues within the immunoreceptor tyrosine-based activation motifs (ITAMs) on distinct TCR subunits (4). ZAP-70 and Syk then recruit to the phosphorylated ITAMs and interact with two phosphotyrosyl residues within an ITAM via their tandem SH2 domains. Only then can ZAP-70 undergo tyrosine phosphorylation and become enzymatically active (5, 6). The subsequent tyrosine phosphorylation of additional cellular substrates, including LAT, phospholipase Cgamma 1, Vav, SLP-76, Shc, Cbl, and Pyk2, function to couple the receptor to its signaling pathways and regulate the activation response.

Members of the group of adapter proteins, which include Crk, Grb2, Nck, Grap, and Shc, consist primarily of SH2 and SH3 protein-protein interaction domains. They are involved in the control of various cellular processes linked to cell growth and differentiation. Crk adapter proteins have been implicated in signaling pathways leading to cell growth (7), migration (8), differentiation (9), apoptosis (10), and transformation (11). Although the physiological role of Crk proteins is largely unknown, studies have shown their involvement in signaling via diverse membrane receptors, including those of integrins (12), interleukins (13), and growth factors (13-15). Furthermore, Crk proteins play a role in signaling via antigen receptors in B (16-18) and T (19-22) lymphocytes. Recent data suggest that the involvement of Crk proteins in various signaling pathways is mediated by their ability to up-regulate the activity of small GTP-binding proteins, such as Ras (15, 23, 24), Rap1 (25, 26), and Rho (27), and activate a selective mitogen-activated protein kinase cascade which is controlled by c-Jun NH2-terminal kinase (23, 28).

Crk proteins have also been reported to interact with a variety of cellular proteins. These include tyrosine-phosphorylated proteins, such as the multidomain docking proteins, Cas (Crk-associated substrate, p130; see Ref. 29) and HEF1 (human enhancer for filamentation 1; see Ref. 30), tyrosine kinase receptors such as the PDGF-R (31), HEK2 (32), and Ret (33), and additional proteins including paxillin (p70; see Ref. 34), Cbl (p120; see Ref. 19), and IRS-1 (insulin receptor substrate-1; see Ref. 35), most of which interact with the Crk SH2 domain. Furthermore, Crk can interact via its SH3 domain with proline-rich sequences in the guanine nucleotide exchange factors, C3G (36) and Sos (24), in Abl (37) and Arg PTKs (38), in addition to proteins that include DOCK180 (39) and EPS15 (40). Nevertheless, the precise role of Crk in the relevant signaling pathways has not been defined.

To analyze further the involvement of Crk proteins in the early activation events in T lymphocytes, we searched for T cell-derived tyrosyl phosphoproteins that associate with Crk in an activation-dependent manner. In this report, we describe experiments showing that the ZAP-70 PTK interacts with Crk in activated T lymphocytes. We also provide data to establish the mechanism of interaction between the two molecules and determine the activity and subcellular location of the Crk-associated ZAP-70.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Reagents-- Phytohemagglutinin, histopaque-1077, glutathione S-transferase (GST), phenylmethylsulfonyl fluoride, aprotinin, and leupeptin were from Sigma. AEBSF was from ICN Biomedicals, Inc. (Aurora, OH). Human recombinant IL-2 was a gift from Hoffmann-LaRoche. Nitrocellulose membranes were from Schleicher & Schuell; ECL was from Amersham Pharmacia Biotech (Buckinghamshire, UK); protein A-Sepharose was from Amersham Pharmacia Biotech (Uppsala, Sweden); and [gamma -32P]ATP (3000 Ci/mmol) was from Rotem Industries, Ltd. (Beer Sheva, Israel). The cdb3/T7-7 expression vector, containing the cytoplasmic domain (residues 1-379) of human erythrocyte band 3 (CFB3) gene, was a gift of Dr. P. S. Low (Purdue University, IN). This construct was used to transform Escherichia coli BL21 (DE3)(pLysS) (Novagen, Madison, WI), and expression and purification of CFB3 were performed essentially as described (41).

Antibodies-- Anti-phosphotyrosine (PY) mAbs were either from culture supernatants of PY.72.10.5 hybridoma (a gift from Dr. B. Sefton, the Salk Institute, La Jolla, CA) or 4G10 mAb from Upstate Biotechnology Inc. (Lake Placid, NY). Cross-reactive anti-Crk-I/Crk-II polyclonal antiserum was raised in rabbits by immunization with a GST-Crk-II fusion protein, and a mouse mAb specific to Crk-I/Crk-II was from Transduction Laboratories (Lexington, KY). Rabbit anti-ZAP-70 polyclonal antiserum was raised against GST fusion protein containing amino acids 255-345 of human ZAP-70, a gift of Dr. J. B. Bolen (Bristol-Myers Squibb Co.) (41). Affinity purified anti-human CD3 mAb was obtained from ascites of the OKT3 hybridoma (obtained from the ATCC, Rockville, MD), and the TCRbeta -chain-specific mAb C305 was a gift of Dr. A. Weiss (University of California, San Francisco, CA). A mouse mAb anti-GST was from Santa Cruz Biotechnology, Inc. Horseradish peroxidase (HRP)-conjugated sheep anti-mouse or donkey anti-rabbit, immunoglobulin Abs, and HRP-conjugated protein A were from Amersham Pharmacia Biotech.

GST Fusion Proteins-- A plasmid containing the GST-CrkL was a gift of Dr. B. Druker (Oregon Health Sciences Center, Portland, OR), and plasmids containing GST fused to Crk-I, Crk-II, or individual Crk-II domains were gifts of Dr. M. Matsuda (National Institute of Health, Tokyo, Japan). pGEX plasmids were used to transform E. coli DH5alpha cells (Life Technologies, Inc.). After induction of protein expression with 0.1 mM isopropyl-1-thio-beta -D-galactopyranoside (Promega, Madison, WI) for 2-4 h, the bacteria were resuspended in a lysis buffer containing 50 mM Tris/HCl, pH 8.0, 100 mM NaCl, and 1 mM phenylmethylsulfonyl fluoride and further disrupted by sonication. Following centrifugation at 10,000 × g for 20 min, the induced proteins were adsorbed to immobilized glutathione-agarose. Soluble GST fusion proteins were obtained by elution with 5 mM reduced glutathione (Roche Molecular Biochemicals, Mannheim, Germany) in 50 mM Tris/HCl, pH 8.0.

For in vitro binding assays, bead-adsorbed GST or GST fusion proteins (5 µg/sample) were incubated with cell lysates at 4 °C on a rotator for 1 h. The beads were then washed 3 times in lysis buffer, and bound proteins were either eluted and subjected to SDS-PAGE under reducing conditions followed by immunoblotting or tested in an in vitro kinase assay.

Cell Culture and Stimulation-- Human leukemic Jurkat T cells, Jurkat-TAg cells which stably express the simian virus 40-derived large T antigen, and Jurkat-derived mutant cell lines, JCaM1 and J4501, that are defective in expression of Lck or CD45, respectively, were maintained at a logarithmic growth phase in complete RPMI (RPMI 1640 supplemented with 5% heat-inactivated fetal calf serum, 2 mM L-glutamine, 50 units/ml penicillin, 50 µg/ml streptomycin (all from Biological Industries, Beit Haemek, Israel), and 5 × 10-5 M beta -mercaptoethanol (Sigma)) in 75-cm2 growth-area tissue culture flasks (Cell-Cult, Sterilin Limited, Feltham, UK) in an atmosphere of 7.5% CO2, at 37 °C. Peripheral blood lymphocytes (PBL) were obtained by histopaque gradient centrifugation of heparinized blood from healthy volunteers. Enriched population of preactivated and rested PBL T cells were obtained by cell culture (1 × 106/ml) in 10% fetal calf serum-containing complete RPMI in the presence of 5 µg/ml phytohemagglutinin in 75-cm2 growth-area tissue culture flasks (50 ml/flask). Human recombinant IL-2 (20 units/ml) was added after 72 h of culture, and cells were maintained in culture for 6 more days by the addition of IL-2 (20 units/ml) once every 2 days.

Jurkat or PBL T cells (10 × 106/100 µl) were stimulated with freshly prepared 1% pervanadate (10 mM Na3VO4 containing 1% H2O2) for 30 min at 37 °C. Ab-mediated cross-linking of the TCR/CD3 was performed by incubating Jurkat or PBL T cells (10 × 106/100 µl) with C305 mAb, or OKT3 mAb, respectively, for 10 min on ice. A secondary cross-linking rabbit anti-mouse Ig Ab was then added for 10 min on ice, followed by transfer to 37 °C and incubation for 2 min.

Mammalian Expression Vectors and Transient Transfection of Cells-- The CRK-II cDNA in pcDL-SRalpha 296(BglII) mammalian expression vector (pVCrk-II) was a gift of Dr. Matsuda (42). For transfection, the Jurkat-TAg cells were washed three times in supplement-free RPMI 1640, resuspended at 5 × 107 cells per ml in unsupplemented medium, and aliquoted into 0.4-cm-gap Gene Pulser cuvettes (Bio-Rad) (2 × 107 cells/400 µl/cuvette). Plasmid DNA (10 µg/group) was added, and the cells were electroporated using a Bio-Rad Gene Pulser (250 volts, 950 microfarads). The cells were then cultured in 13 ml of complete RPMI 1640 in T25 tissue culture flasks for 48 h.

Preparation of Cell Lysates and Immunoprecipitation-- Cell lysates were prepared by resuspension of cells in a lysis buffer containing 25 mM Tris/HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 1 mM Na3VO4, 50 mM NaF, 10 µg/ml each of leupeptin and aprotinin, 2 mM AEBSF, and 1% Triton X-100, followed by a 20-min incubation on ice. Lysates were centrifuged at 13,000 × g for 30 min at 4 °C, and the nuclear free supernatants were mixed with equal volumes of 2× SDS sample buffer, vortexed, incubated at 100 °C for 5 min, and analyzed by SDS-PAGE. Cytosol and particulate fractions were prepared by resuspending the cells in buffer A (20 mM Tris/HCl, pH 7.5, 2 mM EDTA, 0.5 mM EGTA, 10 mM beta -mercaptoethanol, 10 µg/ml each of leupeptin and aprotinin, and 2 mM AEBSF) and repeatedly aspirating them through a 1-ml syringe with a 26-gauge needle for 20 s. Cell lysates were centrifuged at 400 × g for 5 min; nuclear pellets were removed, and lysates were recentrifuged at 13,000 × g. Supernatants (cytosolic fractions) were transferred to a second set of microcentrifuge tubes, Triton X-100 was added up to a 1% final concentration, and samples were either mixed with 5× SDS sample buffer (4:1, v/v), or used for immunoprecipitation. Pellets were washed once in buffer A, resuspended in buffer A plus 1% Triton X-100 (in the original volume used for the lysis), incubated for 30 min on ice, and centrifuged at 13,000 × g for 20 min. Supernatants (particulate fractions) were either mixed with 5× SDS sample buffer (4:1, v/v) or used for immunoprecipitation.

Immunoprecipitation was performed by using an optimal dilution of polyclonal antisera or mAbs that were preabsorbed on protein A-Sepharose beads for 2 h at 4 °C. Excess Abs were removed by 3 washes in cold phosphate-buffered saline, and Ab-coated beads were incubated with cell lysates for 2-3 h at 4 °C. Immune complexes were precipitated by centrifugation followed by extensive washing in a lysis buffer. Immunoprecipitated proteins were then either fractionated by SDS-PAGE and immunoblotted or subjected to an in vitro kinase assay.

Electrophoresis and Immunoblotting-- Samples of cell lysates, GST fusion protein, GST fusion protein-bound molecules, or Ab immunoprecipitates were resolved by electrophoresis on 10% acrylamide gels using Bio-Rad Mini-PROTEAN II Cell. Proteins in the gels were either stained with Coomassie Brilliant Blue (Sigma) or blotted onto nitrocellulose membranes (Schleicher & Schuell) at 100 V for 45 min in a Bio-Rad Mini Trans-Blot transfer cell. After 1 h blocking at 37 °C with 3% bovine serum albumin in phosphate-buffered saline, nitrocellulose membranes were incubated with the indicated primary Abs, followed by incubation with HRP-conjugated sheep anti-mouse, or donkey anti-rabbit, Ig, or with HRP-conjugated protein A (Amersham Pharmacia Biotech). Immunoreactive proteins were visualized using an ECL reagent (Amersham Pharmacia Biotech) and autoradiography.

Far Western Analysis-- To determine direct interaction of either Crk-II or selected Crk-II domains with the electrophoresed, nitrocellulose-bound proteins, the SDS-PAGE and blotting were performed as described above, followed by blocking of the membranes with phosphate-buffered saline containing 3% bovine serum albumin and 0.1% Tween 20. Membranes were then incubated overnight at 4 °C with a blocking buffer containing 10 µg/ml of the indicated GST fusion protein, or GST, as a negative control. Bound GST proteins were detected by incubation of the membrane with a mouse anti-GST mAb for 1 h, followed by an HRP-conjugated sheep anti-mouse Ig and ECL development.

ZAP-70 Kinase Assay-- ZAP-70 immunoprecipitates or cell lysate proteins adsorbed to immobilized GST fusion protein were washed twice in a lysis buffer followed by an additional wash in a kinase reaction buffer (25 mM HEPES, pH 7.3, 0.1% Nonidet P-40, 10 mM MnCl2, 1 mM Na3VO4, 50 mM NaF). They were then resuspended in a reaction buffer, with or without 1 µg of CFB3. Kinase reaction, in a total volume of 15 µl, was initiated by the addition of 5 µCi of 10 µM [gamma -32P]ATP (at 3000 Ci/mmol) and incubated for 10 min at 30 °C. Reaction was terminated by the addition of 5× SDS sample buffer (4:1, v/v); samples were vortexed and boiled for 5 min, and phosphoproteins were resolved by SDS-PAGE on 10% acrylamide gels. Phosphoproteins were blotted onto nitrocellulose membranes and visualized by autoradiography by exposure to Kodak XAR-5 x-ray film at -70 °C with an intensifying screen.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Crk Adapter Proteins Associate with ZAP-70 from Activated Jurkat T Cells-- Adapter proteins that consist of SH2 and SH3 domains play critical roles in the assembly of multimolecular signaling complexes during the early phases of cell activation response. We analyzed the involvement of Crk adapter proteins in the regulation of T cell activation, and because many of the protein-protein interaction events are regulated by tyrosine phosphorylation of signaling molecules, we questioned whether Crk proteins interact with tyrosine-phosphorylated proteins in activated T cells. Lysates of non-activated or pervanadate-stimulated human Jurkat T cells were incubated with bead-immobilized GST-Crk fusion proteins. After separation of the bound proteins by SDS-PAGE, the proteins were transblotted to nitrocellulose membranes, and tyrosyl phosphoproteins were identified using phosphotyrosine-specific mAbs. All three Crk adapter proteins were found to pull down numerous protein bands that reacted with anti-phosphotyrosine (Fig. 1A). One of the observed protein bands, at the range of 70 kDa, corresponded to the molecular mass of ZAP-70 PTK, which is a key enzyme in T cell activation. Stripping and reblotting of the membrane with anti-ZAP-70 Abs indicated that Crk interacted with ZAP-70 (Fig. 1A, 6th, 8th, and 10th lanes) and that the association occurred in lysates of activated but not of non-activated T cells (Fig. 1B, 6th, 8th, and 10th lanes, versus 5th, 7th, and 9th lanes, respectively). To examine whether this protein-protein interaction pattern is selective for Crk, we compared it with the pattern of tyrosyl phosphoproteins that associates with two other adapter proteins, Grb2 and Nck, which are also expressed in T cells. Although the overall pattern of tyrosyl phosphoproteins that interact with Crk and Grb2 was not drastically different, ZAP-70 was found to associate with Crk adapter proteins but not with Grb2 or Nck (Fig. 1B, 5-10th versus 11-14th lanes).


View larger version (71K):
[in this window]
[in a new window]
 
Fig. 1.   . Fusion proteins of GST-Crk, but not GST-Grb2 or -Nck, associate in vitro with tyrosine-phosphorylated ZAP-70 from a lysate of pervanadate-stimulated Jurkat T cells. Jurkat cells (4 × 107/group) were incubated with 1% pervanadate (perVO4) for 30 min at 37 °C followed by lysis and incubation of the lysate with 5 µg of GST or GST fusion proteins immobilized to glutathione-agarose beads. After 1 h of incubation on a rotator at 4 °C, the beads were washed, and bound proteins were eluted and subjected to SDS-PAGE under reducing conditions. Proteins were then electroblotted (IB) onto nitrocellulose membranes, and tyrosine-phosphorylated proteins were visualized by reaction with anti-phosphotyrosine (pY) mAbs and development with immunoperoxidase ECL detection system and autoradiography (A). After stripping of the nitrocellulose membranes from bound Abs, membranes were reblotted with Abs specific for ZAP-70 (B). Molecular size markers (in kilodalton) are indicated on the left. The position of the anti-ZAP-70 reactive 70-kDa protein band is indicated by an arrowhead. Results are representative of five experiments.

Depletion of ZAP-70 from the lysate of activated T cells by repeated absorption with bead-immobilized anti-ZAP-70 Abs confirmed that the Crk-associated 70-kDa protein is ZAP-70 and is not a distinct 70-kDa protein that reacts with the secondary anti-rabbit Ab or directly interacts with the ECL (Fig. 2). Furthermore, the GST-Crk-II fusion protein pulled down a tyrosine-phosphorylated 70-kDa protein only from wild-type Jurkat cells but not from its ZAP-70-deficient mutant, P116 (not shown).


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 2.   The 70-kDa phosphoprotein from activated Jurkat T cells which interacts with GST-Crk is depleted by pretreatment with anti-ZAP-70 Abs. A, Jurkat cells (4 × 107/group) were either not treated or were incubated with 1% pervanadate (perVO4) for 30 min at 37 °C followed by treatment with a lysis buffer. Cell lysate supernatants were either not treated or underwent three consecutive immunoprecipitation steps with protein A-agarose-bound anti-ZAP-70 Abs. Supernatants were then incubated with protein A-agarose-bound anti-ZAP-70 Abs (1st lane), 5 µg of GST (2nd lane), or 5 µg of GST-Crk-II immobilized to glutathione-agarose beads (3rd and 4th lanes). After 1 h of incubation on a rotator at 4 °C, the beads were washed, and bound proteins were eluted and subjected to SDS-PAGE and immunoblotting (IB) with anti-ZAP-70 Abs, as described in the legend to Fig. 1. B, supernatants from activated Jurkat T cell lysates that were subjected to 1, 2, or 3 sequential immunoprecipitations with anti-ZAP-70 Abs were analyzed by SDS-PAGE under reducing conditions, electroblotted onto nitrocellulose membranes, and immunoblotted with anti-ZAP-70 Abs, as indicated above. Molecular size markers (in kilodalton) are indicated on the right, and the position of the anti-ZAP-70 reactive 70-kDa protein band is indicated by an arrowhead. Similar results were obtained in two other experiments.

The human ZAP-70 protein possesses 31 tyrosine residues that are potential phosphorylation sites for PTKs in pervanadate-activated T cells. One or more of these phosphotyrosyl residues may possibly mediate binding to the Crk-SH2 but may not necessarily be a potential site in TCR-activated T cells. We therefore tested whether cross-linking of the TCR on Jurkat T cells would also induce phosphorylation of ZAP-70 at a site that allows interaction with Crk. Activation of TCR on Jurkat cells was induced by incubation with a TCR Vbeta -chain-specific mAb, C305, followed by analysis of the interaction of cell lysate proteins with various GST-Crk fusion proteins. The results demonstrated that C305 stimulation of Jurkat cells induced the association of ZAP-70 with Crk and that the binding affinity to the three Crk proteins was markedly distinct, indicating a hierarchy of Crk-II >> CrkL >=  Crk-I (Fig. 3A). This was based on observations of autoradiograms obtained after extended periods of exposure (not shown). Many of the protein bands observed in the anti-ZAP-70 immunoblots reflected the GST portion of the fusion proteins and their degradation products that react with Abs against the GST portion of the immunogen.


View larger version (65K):
[in this window]
[in a new window]
 
Fig. 3.   . GST-Crk associates in vitro with ZAP-70 from lysates of TCR-stimulated Jurkat T cells and peripheral blood T cells. Jurkat cells (4 × 107/group, A) or peripheral blood lymphocytes (4 × 107/group, B and C) were incubated with either TCR Vbeta -chain-specific mAb, C305 (A), or anti-CD3, OKT3 mAb (B and C), for 2 min at 37 °C, followed by lysis and incubation of the lysate with 5 µg of GST or GST fusion proteins immobilized to glutathione-agarose beads. After 1 h of incubation on a rotator at 4 °C, the beads were washed, and bound proteins were eluted and subjected to SDS-PAGE under reducing conditions. Proteins were then electroblotted onto nitrocellulose membranes followed by incubation with anti-ZAP-70 Abs and immunoperoxidase ECL detection system. Immunoreactive proteins were visualized by autoradiography (A and B). After stripping, the nitrocellulose membranes were reblotted with phosphotyrosine-specific mAbs (C). Molecular size markers (in kilodalton) are indicated on the left. The position of the anti-ZAP-70 reactive 70-kDa protein band is marked with an arrowhead. Results are representative of four experiments performed on Jurkat cells (A) and three experiments performed on peripheral blood lymphocytes obtained from three independent donors (B). pY, phosphotyrosine.

To analyze further whether ZAP-70-Crk association represents a general phenomenon in activated T cells, or perhaps an event unique for Jurkat cells or leukemic cells, we performed a similar analysis on lymphocytes from human peripheral blood. Because ZAP-70 is expressed in T, but not B, lymphocytes, we used unseparated peripheral blood lymphocytes stimulated with polyclonal anti-CD3 (OKT3) mAbs. As in Jurkat cells, ZAP-70 from OKT3-stimulated peripheral blood T lymphocytes interacted with GST-Crk (Fig. 3B), and distinct Crk proteins exhibited a hierarchy of binding affinities identical to the one observed in Jurkat cells (Fig. 3A). Stripping and re-blotting of the membrane with Tyr(P)-specific mAbs confirmed that a tyrosyl phosphoprotein band with a molecular mass of 70 kDa was pulled down by GST-Crk from a lysate of OKT3-stimulated, but not resting, PBL (Fig. 3C).

To demonstrate the interaction between ZAP-70 and Crk in activated T cells in a more direct way, Jurkat cell lysates were subjected to immunoprecipitation with either anti-Crk or anti-ZAP-70 Abs and blotting with the reciprocal combination of Abs. We found that Crk mAbs co-immunoprecipitated ZAP-70 from a lysate of activated but not non-activated Jurkat cells (not shown). Because of the relatively low stoichiometry of binding obtained in this assay, we repeated the immunoprecipitation in Jurkat-TAg cells that transiently overexpressed the Crk-II cDNA. As previously, anti-Crk mAbs were found to co-immunoprecipitate ZAP-70; association between the two proteins was specific for activated, but not non-activated, T cells (Fig. 4). The reciprocal immunoprecipitation with anti-ZAP-70 Abs and immunoblotting with anti-Crk did not yield conclusive results. This could be due to the fact that the anti-ZAP-70 polyclonal antiserum cross-reacts with additional proteins that interfere with the analysis and/or the possibility that anti-ZAP-70 Abs compete with Crk in binding to the same epitopes on the ZAP-70 molecule.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 4.   ZAP-70 from a lysate of pervanadate-stimulated Jurkat T cells co-immunoprecipitates (IP) with Crk proteins. Jurkat cells (2 × 107/cuvette) were electroporated with 10 µg of pVCrk-II DNA, cultured for an additional 48 h at 37 °C, and then stimulated with 1% pervanadate (perVO4) for 30 min at 37 °C. Cells were treated with lysis buffer, and lysates were incubated with 2 µg of anti-Crk mAbs (or non-relevant serum (NRS), as a control) plus protein A-conjugated agarose beads. After 1 h of incubation on a rotator at 4 °C, the beads were washed, and bound proteins were eluted and subjected to SDS-PAGE under reducing conditions. Proteins were then electroblotted (IB) onto nitrocellulose membranes, and ZAP-70 proteins (A) were visualized by reaction with specific Abs and an immunoperoxidase ECL detection system followed by autoradiography. After stripping, the nitrocellulose membranes were reblotted with Abs specific for Crk (B). Molecular size markers (in kilodalton) are indicated on the left, and the position of ZAP-70 and Crk protein bands is indicated by arrowheads. Results are representative of three experiments.

ZAP-70 Association with Crk Is Mediated by Direct Physical Interaction of ZAP-70 Phosphotyrosine-containing Sequences with the Crk-SH2 Domain-- The apparent dependence of association between ZAP-70 and Crk on the activation stage of the T cells suggested that this transient event is regulated by a PTK that phosphorylates ZAP-70 and increases its affinity to the Crk-SH2 domain. A PTK candidate for this function is the Src family member, Lck, which was shown to function as an upstream regulator of ZAP-70 (43). In order to test the involvement of Lck in the regulation of ZAP-70 association with Crk, we used the JCaM1 cells, a Jurkat mutant subline that is genetically deficient in Lck. Anti-ZAP-70 blot (Fig. 5B, lower panel) demonstrated that JCaM1 cells possess ZAP-70 protein at levels indistinguishable from those observed in wild-type Jurkat cells. Absence of Lck resulted in a complete lack of activation-dependent tyrosine phosphorylation of ZAP-70 (Fig. 5B, upper panel), which correlates with the lack of association of ZAP-70 with GST-Crk-II (Fig. 5A).


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 5.   ZAP-70 interaction with Crk-II is dependent on Lck and requires phosphorylation of tyrosine residues. Wild-type Jurkat cells and two Jurkat-derived mutant sublines, JCaM1 and J4501, were either not stimulated or incubated with 1% pervanadate (perVO4) for 30 min at 37 °C, followed by lysis, and incubation of the lysate (4 × 107 cell eq per group) with 5 µg of GST or GST-Crk-II fusion proteins immobilized to glutathione-agarose beads. After 1 h of incubation on a rotator at 4 °C, the beads were washed, and bound proteins were eluted and subjected to SDS-PAGE under reducing conditions. Proteins were then electroblotted onto nitrocellulose membranes, and ZAP-70 was visualized by reaction with specific Abs, development with immunoperoxidase ECL detection system, and autoradiography (A). To quantitate ZAP-70 in total cell lysates and determine its tyrosine phosphorylation state, ZAP-70 was immunoprecipitated from a second set of aliquots of the cell lysates (4 × 107 cell eq per group) and immunoblotted (IB) with anti-ZAP-70 Abs (B, lower panel), followed by stripping of the membranes and reblotting with anti-Tyr(P) (anti-pY) mAbs (B, upper panel). Tyrosine phosphorylation levels of proteins in total cell lysates were determined on a third aliquot of cell lysates (0.5 × 106 cell eq per group) by immunoblotting with anti-Tyr(P) mAbs (C). Molecular size markers (in kilodalton) are indicated on the left. The position of ZAP-70 is indicated by an arrowhead. Results are representative of three separate experiments using the three different cell lines.

A second mutant Jurkat subline, termed J4501, that was tested lacks the CD45 protein tyrosine phosphatase and is impaired in TCR-linked signal transduction because of the critical role of CD45 in dephosphorylating essential effector molecules during the early phase of the activation response (44). Even though tyrosine phosphorylation levels of multiple protein bands were reduced or even completely absent in activated J4501 cells (Fig. 5C), the levels of tyrosine-phosphorylated Lck and ZAP-70 in J4501 appeared to be comparable to those of wild-type Jurkat T cells (Fig. 5C). Accordingly, pervanadate stimulation of J4501 cells resulted in association of ZAP-70 with GST-Crk-II (Fig. 5A). These results indicate that ZAP-70 phosphotyrosyl-containing sequences are involved in ZAP-70 interaction with Crk-II and suggest that Lck plays a critical regulatory role in this association. Furthermore, the requirement of ZAP-70 phosphotyrosyl residues in the interaction suggests the involvement of the Crk-SH2 domain. This has been substantiated in binding studies showing that the Crk-SH2 domain (Fig. 6, 5th lane) was sufficient for mediating the interaction with ZAP-70 from a lysate of activated Jurkat T cells, whereas neither of the two Crk-SH3 domains (Fig. 6, 6th and 7th lanes) could bind ZAP-70.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 6.   Interaction of Crk-II with tyrosine-phosphorylated ZAP-70 is mediated by the Crk-II-SH2 domain. Jurkat cells (4 × 107/group) were either left unstimulated or incubated with 1% pervanadate (perVO4) for 30 min at 37 °C, followed by lysis and incubation of the lysate with 5 µg of GST or GST fusion proteins immobilized to glutathione-agarose beads. After 1 h of incubation on a rotator at 4 °C, the beads were washed, and bound proteins were eluted and subjected to SDS-PAGE under reducing conditions on two parallel gels. Proteins were then electroblotted (IB) onto nitrocellulose membranes and ZAP-70 (upper panel), or tyrosine-phosphorylated proteins (lower panel) were visualized by reaction with the appropriate Abs, development with immunoperoxidase ECL detection system, and autoradiography. Total cell lysate of non-activated and pervanadate-stimulated cells (0.5 × 106/group) is included as a reference (lanes 1 and 2). Molecular size markers (in kilodalton) are indicated on the left. The position of ZAP-70 is indicated by an arrowhead. Results are representative of four experiments.

The results thus far indicated that the interaction between ZAP-70 and Crk is dependent on cell activation and tyrosine phosphorylation of ZAP-70 and mediated by the Crk-SH2 domain. However, it is yet unclear whether the two proteins interact via a direct physical contact or through a third party mediator molecule which associate simultaneously with ZAP-70 and Crk. To distinguish between these two possibilities, we used a far Western blot analysis (overlay assay) in which direct binding of soluble fusion proteins to immunoblotted ZAP-70 was tested. We found that GST fusion proteins containing either the entire Crk-II molecule (Fig. 7B) or the isolated Crk-SH2 domain (Fig. 7C) directly interacted with ZAP-70 from pervanadate-stimulated Jurkat T cells. Despite the fact that similar levels of ZAP-70 were immunoprecipitated from non-activated or activated Jurkat cells (Fig. 7D), GST-Crk-II and GST-Crk-II-SH2 interacted with ZAP-70 from activated but not from non-activated T cells (Fig. 7, B and C). Neither Crk-SH3(N) nor Crk-SH3(C) interacted with ZAP-70 in this assay (not shown).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 7.   Physical binding of ZAP-70 to the Crk-SH2 domain is mediated by direct interaction. Protein A-agarose-bound anti-ZAP-70 Abs or normal rabbit serum (NRS), as a negative control, were used for immunoprecipitation (IP) of proteins from nuclei-free lysates of either unstimulated or pervanadate (perVO4)-stimulated Jurkat cells (4 × 107/group). After 1 h incubation on a rotator at 4 °C, the beads were spun down, washed three times in a lysis buffer, and subjected to SDS-PAGE under reducing conditions, followed by electroblotting (IB) onto nitrocellulose membranes. Membranes were then reacted with anti-phosphotyrosine (pY) mAbs (A), soluble GST-Crk-II (B) or GST-Crk-II-SH2 (C) fusion proteins, or anti-ZAP-70 Abs (D). Membrane-bound GST fusion proteins were detected by incubation with mouse anti-GST mAbs. Immunoreactive protein bands were visualized by reaction with an HRP-conjugated secondary Ab and development with an immunoperoxidase ECL detection system followed by autoradiography. Anti-Tyr(P) immunoblot of total cells lysate of non-activated and activated Jurkat cells (0.5 × 106/group) served to control the efficiency of activation (A, right panel). Molecular size markers (in kilodalton) are indicated on the right, and the position of the ZAP-70 protein band is indicated by an arrowhead. Results are representative of three experiments.

The Crk-associated ZAP-70 from Activated Jurkat T Cells Is Enzymatically Active-- The analysis of ZAP-70-deficient human SCID patients has established that ZAP-70 is critical for T cell activation (45-47). ZAP-70 appears to be inactive in resting cells and, upon TCR engagement, undergoes tyrosine phosphorylation and activation. In order to determine whether the Crk-associated ZAP-70 is enzymatically active, we immunoprecipitated Crk, and ZAP-70 for comparison, from activated Jurkat T cells and performed an immune complex kinase assay on the precipitate. A 70-kDa radiolabeled protein band was observed in both ZAP-70 and Crk immunoprecipitates (Fig. 8A, upper panel), suggesting the presence of catalytically active autophosphorylating ZAP-70 in the Crk immunoprecipitate. Furthermore, the Crk co-immunoprecipitating kinase phosphorylated a ZAP-70-specific exogenous substrate, CFB3 (Fig. 8A, lower panel). Proteins that were pulled down from a lysate of activated Jurkat cells, using bead-immobilized GST-Crk-SH2 fusion protein, exhibited a similar phosphorylating activity (Fig. 8B), indicating that the Crk-SH2 domain-associated ZAP-70 was enzymatically active. As expected, the active ZAP-70 interacted with the GST-ZAP-70-SH2 domains, which served as a positive control. This was due to the ability of the tyrosine-phosphorylated TCR-zeta -chain, which possesses three tandem binding sites for ZAP-70, to interact simultaneously with the fusion protein and with Jurkat cell-derived endogenous ZAP-70. In contrast, GST alone or GST-Grb2-SH2, which cannot bind ZAP-70, did not exhibit phosphorylation of either the 70- or the 42-kDa (CFB3) protein bands (Fig. 8).


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 8.   The Crk-associated ZAP-70 from activated Jurkat T cells is enzymatically active. Jurkat cells (4 × 107/group) were incubated with 1% pervanadate for 30 min at 37 °C followed by lysis and incubation of the lysate with the indicated protein A-agarose-bound Abs (A) or the indicated bead-immobilized GST fusion proteins (B). After 1 h incubation on a rotator at 4 °C, the beads were spun down, washed three times in lysis buffer, and subjected to immune complex kinase assay in the presence of [gamma -32P]ATP, with (A, lower panel, and B) or without (A, upper panel) 1 µg of CFB3 as a substrate. Samples were boiled for 5 min and subjected to SDS-PAGE under reducing conditions, and radioactive protein bands were visualized by autoradiography. Molecular size markers (in kilodalton) are indicated on the right, and the positions of radiolabeled protein bands corresponding to ZAP-70 and CFB3 are indicated on the left. Results are representative of three experiments.

Predominant Association of ZAP-70 and Crk Occurs at the Membrane Fraction-- The transient activation of ZAP-70, which follows triggering of the TCR, is correlated with its translocation to the cell membrane and association with tyrosine-phosphorylated ITAM sequences on the TCR-zeta -chain and CD3 subunits (4). The association of ZAP-70 with Crk occurred only in activated T cells following phosphorylation of ZAP-70 on tyrosine residues, suggesting that this event may also take place at the level of the plasma membrane. We therefore fractionated lysates of activated Jurkat T cells and determined the presence of ZAP-70 in general, and tyrosine-phosphorylated ZAP-70 in particular, in each fraction. We also tested the ability of these molecules to associate with the GST-Crk-SH2 fusion protein. As previously, the association of ZAP-70 with the Crk-SH2 domain was found to be dependent on cell activation (Fig. 9). Furthermore, although similar levels of tyrosine-phosphorylated ZAP-70 were observed in the cytosol and particulate fractions, association with the Crk-SH2 domain occurred predominantly at the particulate fraction.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 9.   GST-Crk fusion proteins interact predominantly with membrane fraction-residing tyrosine-phosphorylated ZAP-70. Jurkat cells (4 × 107/group) were either untreated or stimulated with 1% pervanadate (perVO4) for 30 min at 37 °C, followed by treatment with lysis buffer (A, lane 5) or fractionation into cytosolic (cyt) and particulate (mem) fractions (1st to 4th lanes). Cell lysate supernatants were then incubated with 5 µg of GST-Crk-II-SH2 immobilized to glutathione-agarose beads (1st to 4th lanes) or protein A-agarose-bound anti-ZAP-70 Abs (5th lane). After 1 h of incubation on a rotator at 4 °C, the beads were washed, bound proteins were eluted and subjected to SDS-PAGE and immunoblotting with anti-ZAP-70 Abs (A). Supernatants from the same cell fractions were also used as a source for ZAP-70 immunoprecipitation followed by SDS-PAGE and sequential immunoblotting with anti-ZAP-70 (B) and anti-Tyr(P) Abs (C). Protein samples were either form 4 × 107 cell eq (1st to 4th lanes), or 2 × 105 cell eq (5th lane). Molecular size markers (in kilodalton) are indicated on the right, and the position of the ZAP-70 protein band is indicated by an arrowhead. Results are representative of three experiments.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Crk proteins have been implicated in signaling cascades that are linked to various cell-surface receptors, including the antigen receptors on B (16-18) and T (19-22) lymphocytes. Engagement of the BCR in RAMOS cells induced the association of tyrosine-phosphorylated Cas and Cbl with the Crk-SH2 domain, predominantly in the particulate fraction of activated B cells (16). In addition, Vav was inducibly associated with Crk in BCR-stimulated tonsilar B cells (17), and C3G, which catalyzes guanosine triphosphate (GTP) exchange on Rap1 (17, 25), constitutively associated with the Crk SH3 domain. Since C3G functions as a negative regulator of Ras (48), it has been suggested that Crk proteins function by down-regulating BCR-induced Ras-dependent signaling pathways.

Analysis of T lymphocytes revealed that Crk proteins associate with Cbl (19, 20) and Cas-L (49) in an activation-dependent manner and with C3G in a constitutive manner (50). The latter study also suggested that Rap1, which operates downstream of C3G, functions as a negative regulator of the TCR-mediated IL-2 gene transcription and thereby contributes to the maintenance of T cell anergy (50).

Our present findings demonstrate that T cell-derived Crk proteins undergo cell activation-dependent association with the ZAP-70 PTK. Association between the two molecules requires tyrosine phosphorylation of ZAP-70 and is mediated by direct physical contact between the Crk-SH2 domain and ZAP-70 phosphotyrosyl-containing sequences. We also found that binding of ZAP-70 to adapter proteins in T cells is selective and specific to Crk, but not Grb2, or Nck. This is in contrast to other phosphoproteins, such as Cbl, that can interact with Crk (20), Grb2 (51), and Nck (52) adapter proteins. Furthermore, the Crk-associated ZAP-70 was found to be enzymatically active and, apart from undergoing autophosphorylation, could phosphorylate a ZAP-70-specific substrate, CFB3. The possibility that the Crk-associated kinase reflects a PTK other than ZAP-70 cannot be completely ruled out. However, depletion of ZAP-70 from a lysate of activated Jurkat cells also removed the PTK that was pulled down by GST-Crk (Fig. 2) and significantly reduced the phosphorylating activity toward the 70- (ZAP-70) and 42-kDa (CFB3) protein bands (not shown).

The ZAP-70 PTK is a key regulator of signaling in T lymphocytes, and its absence leads to a complete loss of the ability of T cells to respond to antigenic stimuli (45-47). Activity of ZAP-70 is directly regulated by the TCR which, upon engagement with a major histocompatibility complex-bound peptide antigen, undergoes phosphorylation by tyrosine kinases. Phosphorylation occurs at ITAM sequences in the cytoplasmic tails of the TCR zeta -chain and CD3 subunits (53, 54). These phospho-ITAMs function as scaffolds for catalytically inactive ZAP-70, and direct physical binding occurs by a cooperative interaction of the ZAP-70 tandem SH2 domains with doubly tyrosine-phosphorylated ITAMs (43, 55). Whereas TCR-bound ZAP-70 is found in both agonist-responsive active T cells and antagonist-responsive anergic T cells, ZAP-70 undergoes tyrosine phosphorylation and activation only upon productive stimulation with an agonistic peptide antigen (56, 57). Further studies demonstrated that Lck is the putative ZAP-70-phosphorylating kinase (43) and that a single tyrosine residue in the activation loop of the ZAP-70 kinase domain (Tyr493) is critical for activation of the enzyme. Therefore, phosphorylation of Tyr493 enables opening of the activation loop of ZAP-70 which becomes more accessible to potential cellular substrates (5, 6).

The findings that Crk association with ZAP-70 is activation-dependent (Figs. 1, 3, and 4), together with the observation by Iwashima et al. (43) that Lck is the upstream regulator of ZAP-70, raised the question whether Lck is involved in the regulation of ZAP-70 association with Crk. The analysis of the Jurkat mutant subline, JCaM1, which is deficient in Lck, confirmed our hypothesis and demonstrated that ZAP-70-Crk association occurs in activated wild-type Jurkat cells but not in activated Lck-deficient mutant cells (Fig. 5).

It is well established that T cell activation induces the association of ZAP-70 with TCR pITAMs, but the fraction of the total ZAP-70 proteins associated with pITAMs and the subcellular distribution of ZAP-70 in resting cells is still unclear. An overexpressed GFP-ZAP-70 was found to be diffusely distributed throughout the quiescent cell, and it accumulated at the plasma membrane upon cell activation (58). However, a large amount of ZAP-70 resided in the nucleus of quiescent cells and, upon cell activation, underwent tyrosine phosphorylation (58). In another study, the endogenous ZAP-70 was found to localize to the cell cortex in a diffuse band and exhibit similar distribution following TCR stimulation (59). This pattern of distribution was dependent on the ZAP-70 kinase domain and not on the SH2-containing regulatory region. Our studies demonstrate that about one-quarter of the cellular ZAP-70 is found in the membrane fraction of non-activated Jurkat cells and that a significant fraction of the cytosolic ZAP-70 translocate to the membrane fraction upon cell stimulation. Cell activation resulted in tyrosine phosphorylation of ZAP-70 at both the cytosolic and membrane fractions. However, the predominating tyrosine-phosphorylated ZAP-70 that interacted with Crk-SH2 was membrane-derived. The results suggest differences in the ability of phosphotyrosyl residues of cytosolic and membrane-derived ZAP-70 to interact with the Crk-SH2 domain. This may also reflect diversity in the conformation of the molecules or differential association of ZAP-70 with other cell components. Alternatively, it is possible that despite the fact that the phosphorylation levels of membranous and cytosolic ZAP-70 are similar, the sites of phosphorylation of ZAP-70 in the two cellular fractions may differ, and only membranous ZAP-70 undergoes phosphorylation at regions that function as binding sites for the Crk-SH2 domain.

Recent findings demonstrated that the plasma membrane of cells contain detergent-insoluble rafts enriched in glycolipids and phosphatidylinositol-anchored membrane proteins (60, 61). T cell activation results in membrane compartmentalization and accumulation in the rafts of activated TCR and associated signal-transducing molecules (60, 62). The formation of activation-dependent clusters of TCR-containing multimolecular complexes at the site of interaction of T cells with the antigen-presenting cells has also been confirmed by fluorescence digital imaging (3). It is interesting to note that this process is followed by translocation of tyrosine-phosphorylated ZAP-70 to the rafts (59), questioning the possibility that the mechanism of translocation may involve, or even require, the direct interaction of phospho-ZAP-70 with Crk proteins.

Determination of sequence specificity of the peptide-binding sites of various SH2 domains demonstrated that the Crk-SH2 prefers sequences with a general motif pYXXP or, more specifically, pYDHP (where pY indicates phosphotyrosine) (63). Although an identical sequence has not been found in ZAP-70, the protein possesses three YXXP motifs, in which Tyr is at positions 221 (Y221CIP), 315 (Y315ESP), and 319 (Y319SDP) (64). Tyr315 is a putative phosphorylation site on ZAP-70 in activated T cells, and the Y315ESP region serves as an in vivo binding site for the Vav SH2 domain (65). Although it is not yet known whether all three tyrosine residues in the YXXP motifs undergo phosphorylation in activated T cells, the current data suggest that Crk interaction with ZAP-70 is mediated via one of these three pYXXP motifs.

The findings that Crk functions as a positive regulator of apoptosis in Xenopus eggs have indicated that the v-crk-induced transformation of cells may not only reflect interference with the normal growth-regulating signals but also perturbation of signaling pathways that control cell death (10). The complexity of the TCR enables the recognition and binding of specific peptide antigens and sorting of the resulting signal into one of several signaling pathways, including the apoptotic pathway. Although the role of Crk in T lymphocytes is still elusive, its association with ZAP-70 which operates immediately downstream of the TCR suggests that Crk may be involved in signaling pathways leading to T cell apoptosis, especially after strong activation conditions, such as those evoked by pervanadate.

The association of ZAP-70 with Crk may serve additional functions in activated T cells. Thus, simultaneous association of Crk with ZAP-70 and a ZAP-70-specific substrate will ensure high and efficient phosphorylation of substrates, even those that occur at low abundance. Studies of Src family members and Abl PTKs have shown that the SH2 domain of these PTKs preferentially bind phosphotyrosyl-containing sequences that are phosphorylated by their own catalytic domain (66, 67). This may lead to consecutive phosphorylation of the substrate proteins. However, this does not apply to ZAP-70 in which the tandem SH2 domains and the catalytic domain interact with completely different sequences (41). Therefore, it is possible that ZAP-70 interaction with Crk serves as a mechanism by which the Crk-SH3 domain selects and/or restricts the putative ZAP-70 substrates which may co-cluster with and become vulnerable to phosphorylation by ZAP-70.

It is also possible that interaction of a ZAP-70-bound Crk protein with cytoskeletal elements via the SH3 domain, or other compartmentalized components in the cell, will permit anchoring of ZAP-70 and increase its concentration at selected subcellular locations where a critical minimal number of PTK molecules is required for signaling. Finally, another potential role for the interaction of tyrosine-phosphorylated ZAP-70 with the Crk-SH2 domain may be maintaining the enzyme as a phosphoprotein in its catalytically active state by protecting it from dephosphorylation by protein tyrosine phosphatases.

    ACKNOWLEDGEMENTS

We thank Drs. J. Bolen, B. Druker, P. S. Low, M. Matsuda, B. Sefton, and A. Weiss for gifts of reagent.

    FOOTNOTES

* This work was supported in part by grants from the Israel Science Foundation, the Israel Academy of Sciences and Humanities, the USA-Israel Binational Science Foundation, the Chief Scientist's office, Israel Ministry of Health, the Israel Cancer Association through the ICA friends in Brazil, and the Israel Cancer Research Fund.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Microbiology and Immunology, Faculty of Health Sciences, Ben Gurion University of the Negev, P. O. Box 653, Beer Sheva 84105, Israel. Tel.: 972-7-647-7267; Fax: 972-7-647-7626; E-mail: noah@bgumail.bgu.ac.il.

    ABBREVIATIONS

The abbreviations used are: TCR, T cell antigen receptor; BCR, B cell receptor; GST, glutathione S-transferase; ITAM, immunoreceptor tyrosine-based activation motifs; SH2, Src homology 2; SH3, Src homology 3; PAGE, polyacrylamide gel electrophoresis; PBL, peripheral blood lymphocytes; PTK, protein tyrosine kinase; HRP, horseradish peroxidase; mAb, monoclonal antibody; AEBSF, 4-(2-aminoethyl)benzenesulfonyl fluoride; Ab, antibody; IL-2, interleukin-2.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Weiss, A., and Littman, D. R. (1994) Cell 76, 263-274[CrossRef][Medline] [Order article via Infotrieve]
2. Isakov, N., Wange, R. L., and Samelson, L. E. (1994) J. Leukocyte Biol. 55, 265-271[Abstract]
3. Monks, C. R. F., Freiberg, B. A., Kupfer, H., Sciaky, N., and Kupfer, A. (1998) Nature 395, 82-86[CrossRef][Medline] [Order article via Infotrieve]
4. Isakov, N. (1998) Adv. Immunol. 69, 183-247[Medline] [Order article via Infotrieve]
5. Chan, A. C., Dalton, M., Johnson, R., Kong, G. H., Wang, T., Thoma, R., and Kurosaki, T. (1995) EMBO J. 14, 2499-2508[Medline] [Order article via Infotrieve]
6. Wange, R. L., Guitian, R., Isakov, N., Watts, J. D., Aebersold, R., and Samelson, L. E. (1995) J. Biol. Chem. 270, 18730-18733[Abstract/Free Full Text]
7. Gesbert, F., Garbay, C., and Bertoglio, J. (1998) J. Biol. Chem. 273, 3986-3993[Abstract/Free Full Text]
8. Klemke, R. L., Leng, J., Molander, R., Brooks, P. C., Vuori, K., and Cheresh, D. A. (1998) J. Cell Biol. 140, 961-972[Abstract/Free Full Text]
9. Tanaka, S., Hattori, S., Kurata, T., Nagashima, K., Fukui, Y., Nakamura, S., and Matsuda, M. (1993) Mol. Cell. Biol. 13, 4409-4415[Abstract/Free Full Text]
10. Evans, E. K., Lu, W., Strum, S. L., Mayer, B. J., and Kornbluth, S. (1997) EMBO J. 16, 230-241[CrossRef][Medline] [Order article via Infotrieve]
11. Mayer, B. J., Hamaguchi, M., and Hanafusa, H. (1988) Nature 332, 272-275[CrossRef][Medline] [Order article via Infotrieve]
12. Vuori, K., Hirai, H., Aizawa, S., and Ruoslahti, E. (1996) Mol. Cell. Biol. 16, 2606-2613[Abstract]
13. Barber, D. L., Mason, J. M., Fukazawa, T., Reedquist, K. A., Druker, B. J., Band, H., and D'Andrea, A. D. (1997) Blood 89, 3166-3174[Abstract/Free Full Text]
14. Teng, K. K., Lander, H., Fajardo, J. E., Hanafusa, H., Hempstead, B. L., and Birge, R. B. (1995) J. Biol. Chem. 270, 20677-20685[Abstract/Free Full Text]
15. Kizaka-Kondoh, S., Matsuda, M., and Okayama, H. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 12177-12182[Abstract/Free Full Text]
16. Ingham, R. J., Krebs, D. L., Barbazuk, S. M., Turck, C. W., Hirai, H., Matsuda, M., and Gold, M. R. (1996) J. Biol. Chem. 271, 32306-32314[Abstract/Free Full Text]
17. Smit, L., van der Horst, G., and Borst, J. (1996) J. Biol. Chem. 271, 8564-8569[Abstract/Free Full Text]
18. Smit, L., van der Horst, G., and Borst, J. (1996) Oncogene 13, 381-389[Medline] [Order article via Infotrieve]
19. Buday, L., Khwaja, A., Sipeki, S., Farago, A., and Downward, J. (1996) J. Biol. Chem. 271, 6159-6163[Abstract/Free Full Text]
20. Sawasdikosol, S., Chang, J. H., Pratt, J. C., Wolf, G., Shoelson, S. E., and Burakoff, S. J. (1996) J. Immunol. 157, 110-116[Abstract]
21. Sawasdikosol, S., Ravichandran, K. S., Lee, K. K., Chang, J. H., and Burakoff, S. J. (1995) J. Biol. Chem. 270, 2893-2896[Abstract/Free Full Text]
22. Reedquist, K. A., Fukazawa, T., Panchamoorthy, G., Langdon, W. Y., Shoelson, S. E., Druker, B. J., and Band, H. (1996) J. Biol. Chem. 271, 8435-8442[Abstract/Free Full Text]
23. Senechal, K., Halpern, J., and Sawyers, C. L. (1996) J. Biol. Chem. 271, 23255-23261[Abstract/Free Full Text]
24. Matsuda, M., Hashimoto, Y., Muroya, K., Hasegawa, H., Kurata, T., Tanaka, S., Nakamura, S., and Hattori, S. (1994) Mol. Cell. Biol. 14, 5495-5500[Abstract/Free Full Text]
25. Gotoh, T., Hattori, S., Nakamura, S., Kitayama, H., Noda, M., Takai, Y., Kaibuchi, K., Matsui, H., Hatase, O., Takahashi, H., Kurata, T., and Matsuda, M. (1995) Mol. Cell. Biol. 15, 6746-6753[Abstract]
26. Okada, S., Matsuda, M., Anafi, M., Pawson, T., and Pessin, J. E. (1998) EMBO J. 17, 2554-2565[CrossRef][Medline] [Order article via Infotrieve]
27. Altun-Gultekin, Z. F., Chandriani, S., Bougeret, C., Ishizaki, T., Narumiya, S., de Graaf, P., Van Bergen en Henegouwen, P., Hanafusa, H., Wagner, J. A., and Birge, R. B. (1998) Mol. Cell. Biol. 18, 3044-3058[Abstract/Free Full Text]
28. Senechal, K., Heaney, C., Druker, B., and Sawyers, C. L. (1998) Mol. Cell. Biol. 18, 5082-5090[Abstract/Free Full Text]
29. Sakai, R., Iwamatsu, A., Hirano, N., Ogawa, S., Tanaka, T., Mano, H., Yazaki, Y., and Hirai, H. (1994) EMBO J. 13, 3748-3756[Medline] [Order article via Infotrieve]
30. Astier, A., Manie, S. N., Law, S. F., Canty, T., Haghayghi, N., Druker, B. J., Salgia, R., Golemis, E. A., and Freedman, A. S. (1997) Leuk. & Lymphoma 28, 65-72[Medline] [Order article via Infotrieve]
31. Yokote, K., Hellman, U., Ekman, S., Saito, Y., Ronnstrand, L., Saito, Y., Heldin, C. H., and Mori, S. (1998) Oncogene 16, 1229-1239[CrossRef][Medline] [Order article via Infotrieve]
32. Hock, B., Böhme, B., Karn, T., Feller, S., Rübsamen-Waigmann, H., and Strebhardt, K. (1998) Oncogene 17, 255-260[CrossRef][Medline] [Order article via Infotrieve]
33. Bocciardi, R., Mograbi, B., Pasini, B., Borrello, M. G., Pierotti, M. A., Bourget, I., Fischer, S., Romeo, G., and Rossi, B. (1997) Oncogene 15, 2257-2265[CrossRef][Medline] [Order article via Infotrieve]
34. Birge, R. B., Fajardo, J. E., Reichman, C., Shoelson, S. E., Songyang, Z., Cantley, L. C., and Hanafusa, H. (1993) Mol. Cell. Biol. 13, 4648-4656[Abstract/Free Full Text]
35. Sorokin, A., Reed, E., Nnkemere, N., Dulin, N. O., and Schlessinger, J. (1998) Oncogene 16, 2425-2434[CrossRef][Medline] [Order article via Infotrieve]
36. Tanaka, S., Morishita, T., Hashimoto, Y., Hattori, S., Nakamura, S., Shibuya, M., Matuoka, K., Takenawa, T., Kurata, T., Nagashima, K., and Matsuda, M. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 3443-3447[Abstract/Free Full Text]
37. Ren, R., Ye, Z. S., and Baltimore, D. (1994) Genes Dev. 8, 783-795[Abstract/Free Full Text]
38. Wang, B., Mysliwiec, T., Feller, S. M., Knudsen, B., Hanafusa, H., and Kruh, G. D. (1996) Oncogene 13, 1379-1385[Medline] [Order article via Infotrieve]
39. Hasegawa, H., Kiyokawa, E., Tanaka, S., Nagashima, K., Gotoh, N., Shibuya, M., Kurata, T., and Matsuda, M. (1996) Mol. Cell. Biol. 16, 1770-1776[Abstract]
40. Schumacher, C., Knudsen, B. S., Ohuchi, T., Di Fiore, P. P., Glassman, R. H., and Hanafusa, H. (1995) J. Biol. Chem. 270, 15341-15347[Abstract/Free Full Text]
41. Isakov, N., Wange, R. L., Watts, J. D., Aebersold, R., and Samelson, L. E. (1996) J. Biol. Chem. 271, 15753-15761[Abstract/Free Full Text]
42. Matsuda, M., Tanaka, S., Nagata, S., Kojima, A., Kurata, T., and Shibuya, M. (1992) Mol. Cell. Biol. 12, 3482-3489[Abstract/Free Full Text]
43. Iwashima, M., Irving, B. A., van Oers, N. S. C., Chan, A. C., and Weiss, A. (1994) Science 263, 1136-1139[Abstract/Free Full Text]
44. Koretzky, G. A., Picus, J., Schultz, T., and Weiss, A. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 2037-2041[Abstract/Free Full Text]
45. Arpaia, E., Shahar, M., Dadi, H., Cohen, A., and Roifman, C. M. (1994) Cell 76, 947-958[CrossRef][Medline] [Order article via Infotrieve]
46. Chan, A. C., Kadlecek, T. A., Elder, M. E., Filipovich, A. H., Kuo, W. L., Iwashima, M., Parslow, T. G., and Weiss, A. (1994) Science 264, 1599-1601[Abstract/Free Full Text]
47. Elder, M. E., Lin, D., Clever, J., Chan, A. C., Hope, T. J., Weiss, A., and Parslow, T. G. (1994) Science 264, 1596-1599[Abstract/Free Full Text]
48. Hariharan, I. K., Carthew, R. W., and Rubin, G. M. (1991) Cell 67, 717-722[CrossRef][Medline] [Order article via Infotrieve]
49. Ohashi, Y., Tachibana, K., Kamiguchi, K., Fujita, H., and Morimoto, C. (1998) J. Biol. Chem. 273, 6446-6451[Abstract/Free Full Text]
50. Boussiotis, V. A., Freeman, G. J., Berezovskaya, A., Barber, D. L., and Nadler, L. M. (1997) Science 278, 124-128[Abstract/Free Full Text]
51. Donovan, J. A., Wange, R. L., Langdon, W. Y., and Samelson, L. E. (1994) J. Biol. Chem. 269, 22921-22294[Abstract/Free Full Text]
52. Rivero-Lezanco, O. M., Sameshima, J. H., Marcilla, A., and Robbins, K. C. (1994) J. Biol. Chem. 269, 17363-17366[Abstract/Free Full Text]
53. Baniyash, M., Garcia-Morales, P., Luong, E., Samelson, L. E., and Klausner, R. D. (1988) J. Biol. Chem. 263, 18225-18230[Abstract/Free Full Text]
54. Qian, D., Griswold-Prenner, I., Rosner, M. K., and Fitch, F. W. (1993) J. Biol. Chem. 268, 4488-4493[Abstract/Free Full Text]
55. Isakov, N., Wange, R. L., Burgess, W. H., Watts, J. D., Aebersold, R., and Samelson, L. E. (1995) J. Exp. Med. 181, 375-380[Abstract/Free Full Text]
56. Sloan-Lancaster, J., Shaw, A. S., Rothbard, J. B., and Allen, P. M. (1994) Cell 79, 913-922[CrossRef][Medline] [Order article via Infotriev